期刊文献+

结肠癌Prox-1表达与淋巴管密度的关系及其临床意义 被引量:5

Expression of Prox-1 in colorectal carcinoma and its relationship with lymphatic vessel density
下载PDF
导出
摘要 目的观察分析原发性结肠癌中转录因子Prox-1的表达与淋巴管密度(lymphatic vessel density,LVD)的关系,探讨其临床意义。方法对我院收治的50例结肠癌患者的癌旁非癌组织和正常大肠组织,采用逆转录-聚合酶链反应法检测Prox-1表达情况,采用免疫组化SP法检测对应组织中LVD。结果癌旁非癌组织中Prox-1表达水平显著高于正常组织(t=6.232,P<0.05);癌旁非癌组织LVD显著高于正常组织(t=8.627,P<0.05);癌旁非癌组织Prox-1的表达水平与LVD呈正相关(r=0.621,P<0.05),在浸润深度(t=3.310,P<0.05)、TNM分期(t=3.341,P<0.05)及淋巴转移(t=2.689,P<0.05)上差异有统计学意义。结论结肠癌癌旁非癌组织中Prox-1的表达水平较高,且与淋巴转移、浸润深度及TNM分期有关,可作为结肠癌预后判断的有效预测因子之一。 Objective To explore the expression of the transcription factor Prox-1 in colorectal carcinoma and its relationship with lymphatic vessel density, and clinical significance. Methods Fifty colorectal carcinoma patients were included in this study. RT-PCR was used to detect the expression of Prox-1in paracarcinoma tissues and normal colorectal tissues; immunohistochemical method(SP) was used to examine the lymphatic vessel density(LVD). Results The expression of Prox-1 m R NA in paracarcinoma tissues was signif icantly higher than that in nor mal tissues(t = 6.232, P〈0.05); the LV D in paracarcinoma tissues was signif icantly higher than that in nor mal tissues(t =8.627, P〈0.05). The expression of Prox-1 m R NA in paracarcinoma tissues had positively linear relation with LV D(r = 0.621, P〈0.05). The expression of Prox-1 of paracarcinoma tissues in dimension of invasion depth(t =3.310, P〈0.05),T N M staging(t =3.341, P〈0.05) and ly mph node metastasis(t =2.689, P〈0.05) showed signif icant difference. Conclusion The overexpression of Prox-1 i n pa raca rci noma t issue is related to ly mphat ic met ast asis, depth of i nvasion and T N M st age. T he expression of Prox-1 can be one of impor tant prognostic factors for colon cancer.
机构地区 [
出处 《空军医学杂志》 2015年第2期83-85,104,共4页 Medical Journal of Air Force
关键词 转录因子Prox-1 结肠癌 淋巴转移 Prox-1 Colon cancer Lymphatic metastasis
  • 相关文献

参考文献9

  • 1Natarajan E, Saeb M, Crum CP, et al. Co-expression of pl6INK4A and laminin 5 by keratinocytes., a wound -healing response coupling hypermotility with growth arrest that goes awry during epithelial neoplastic progression[J]. Am J Pathol, 2003, 163 (2) : 477.
  • 2Dadras SS, Detmar M. Angiogenesis and lymphangiogenesis ofskin cancers[J]. Hematol Oncol Clin North Am, 2004, 18 (5) : 1059-1070.
  • 3Hong YK, Harvey N, Noh YH, et al. Prox-1 is amaster control gene in the program specifying lymphatic endothelial cell fate [J]. Dev Dyn, 2002, 225 (3) : 351-357.
  • 4李莹,王季堃,李巍,吕凤俊,姜一.rAd-p53联合伊立替康诱导结肠癌细胞株HT-29凋亡的实验研究[J].山东医药,2012,52(11):38-41. 被引量:3
  • 5方骏,孟翔凌.老年结肠癌并肠梗阻32例治疗分析[J].中国现代普通外科进展,2012,15(6):500-501. 被引量:6
  • 6Kawai Y, Shiomi H, Abe H, et al. Cell transplantation therapy for a rat model of secondary lymphedema[J]. J Surg Res, 2014, 189 (1) : 184-191.
  • 7Sleeckx N, Van Brantegem L, Fransen E, et al. Evaluation of Immunohistochemical Markers of Lymphatic and Blood Vessels in Canine Mammary Tumours[J]. J Comp Pathol, 2013, 148 (4) : 307-317.
  • 8Benevenuto de Andrade BA, Ramirez-Amador V, Anaya- Saavedra G, et al. Expression of PROX-1 in oral Kaposi's sarcoma spindle cells[J]. J Oral Pathol Med, 2014, 43 (2) : 132-136.
  • 9Reichelt U, Keichel S, Barcena de Arellano ML, et al. High lymph vessel density and expression of lymphatic growth factors in peritoneal endometriosis[J]. Reprod Sci, 2012, 19 (8) : 876-882.

二级参考文献19

  • 1李进军,伍冀湘,梁杰雄.80岁以上高龄患者腹部手术后肺部感染的诊断与治疗:附79例报告[J].中国普通外科杂志,2005,14(1):75-76. 被引量:17
  • 2陶秀平,唐正华,张裕华.结肠癌并急性肠梗阻的外科治疗(附50例报告)[J].医学临床研究,2005,22(4):549-550. 被引量:12
  • 3孙备,许军,周尊强,刘昶,姜洪池.左半结肠癌并发急性肠梗阻一期切除吻合的合理性与评价[J].中国普外基础与临床杂志,2006,13(1):103-104. 被引量:73
  • 4Brand K,Klocke R,Pobetaling A. Induction of apoptosis and G2/M arrest by infection with replication deficient adenovirus at high multiplicity of infection[J].Gene Therapy,1999,(08):1054-1063.
  • 5Gurnani M,Lipari P,Dell J. Adenovirus-mediated p53 gcne therapy has greater efficacy when combined with chemotherapy against human head and neck,ovarian,prostate,and breastcancer[J].Cancer Chemotherapy and Pharmacology,1999,(02):143-151.
  • 6Ferreira CG,Tolis C,Giaccone G. p53 and chemosensitivity[J].Annals of Oncology,1999,(09):1011-1021.
  • 7Xiang H,Fox JA,Totpal K. Enhanced tumor killing by Apo2L/TRAIL and CPT-11 co-treatment is associated with p21cleavage and differential regulation of Apo2L/TRAIL ligand and its receptors[J].Oncogene,2002,(22):3611-3619.
  • 8Lin JH,Deng G,Huang Q. KIAP,a novel member of the inhibitor of apoptosis protein family[J].Biochemical and Biophysical Research Communications,2000,(03):820-831.doi:10.1006/bbrc.2000.4027.
  • 9Kasof GM,Comes BC. Livin,a novel inhibitor of apoptosis protein family member[J].Journal of Biological Chemistry,2001,(05):3238-3246.doi:10.1074/jbc.M003670200.
  • 10Vucic D,Stennicke HR,Pisabarro MT. MLIAP,a novel inhibitor of apoptosis that is preferentially expressed in human melanomas[J].Current Biology,2000,(21):1359-1366.

共引文献6

同被引文献64

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部